Related references
Note: Only part of the references are listed.The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Immunoglobulin A and the microbiome
Yi Yang et al.
CURRENT OPINION IN MICROBIOLOGY (2020)
Clinical efficacy of mechanical bacterial lysate in the prevention of infectious exacerbations of chronic obstructive pulmonary disease
S. N. Avdeev et al.
TERAPEVTICHESKII ARKHIV (2020)
Prevention of New Respiratory Episodes in Children with Recurrent Respiratory Infections: An Expert Consensus Statement from the World Association of Infectious Diseases and Immunological Disorders (WAidid)
Susanna Esposito et al.
MICROORGANISMS (2020)
The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries
D. M. G. Halpin et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2019)
The role of the lung microbiota and the gut-lung axis in respiratory infectious diseases
Alexia Dumas et al.
CELLULAR MICROBIOLOGY (2018)
Broncho Vaxom (OM-85) modulates rhinovirus docking proteins on human airway epithelial cells via Erk1/2 mitogen activated protein kinase and cAMP
Michael Roth et al.
PLOS ONE (2017)
Effects of OM-85 BV in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
Lei Pan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Efficacy and Safety of OM-85 in Patients with Chronic Bronchitis and/or Chronic Obstructive Pulmonary Disease
Hao Tang et al.
LUNG (2015)
Sub-lingual administration of a polyvalent mechanical bacterial lysate (PMBL) in patients with moderate, severe, or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD spirometric classification: A multicentre, double-blind, randomised, controlled, phase IV study (AIACE study: Advanced Immunological Approach in COPD Exacerbation)
Fulvio Braido et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2015)
The cost-effectiveness of OM-85 in managing respiratory tract infections in China
Jianwei Xuan et al.
JOURNAL OF MEDICAL ECONOMICS (2015)
Immunostimulation using bacterial antigens - mechanism of action and clinical practice in viral respiratory tract infections
Wojciech Feleszko et al.
PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE (2015)
The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes
Rossella Ricci et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2014)
Enhanced mucosal antibody production and protection against respiratory infections following an orally administered bacterial extract
Christian Pasquali et al.
FRONTIERS IN MEDICINE (2014)
Pulmonary-intestinal cross-talk in mucosal inflammatory disease
S. Keely et al.
MUCOSAL IMMUNOLOGY (2012)
The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T cells to the airways
S. Navarro et al.
MUCOSAL IMMUNOLOGY (2011)
Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone
Mario Cazzola et al.
Therapeutic Advances in Respiratory Disease (2009)
Double-blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease
M. Soler et al.
RESPIRATION (2007)
Projections of global mortality and burden of disease from 2002 to 2030
Colin D. Mathers et al.
PLOS MEDICINE (2006)
Mucosal immunity and vaccines
J Holmgren et al.
NATURE MEDICINE (2005)
How should meta-regression analyses be undertaken and interpreted?
SG Thompson et al.
STATISTICS IN MEDICINE (2002)
Selective enhancement of systemic Th1 immunity in immunologically immature rats with an orally administered bacterial extract
LM Bowman et al.
INFECTION AND IMMUNITY (2001)
Share Paper
